PharmaCyte Biotech, Inc. (PMCB) stock
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.42−0.15 (-2.69%)
Close on Nov 17, 2026Market cap $58.19MP/E –Yield –
PharmaCyte Biotech price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
PharmaCyte Biotech's price to sales ratio was 312.3× on Jan 31, 2013.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2013 | Jan 31, 2013 | 312.3× | – |
See a number that looks wrong?